Table I.
Association between TMCC1-AS1 expression and clinicopathological characteristics of patients with hepatocellular carcinoma (n=68).
| TMCC1-AS1 expression | ||||
|---|---|---|---|---|
|
|
||||
| Variable | No. | High, n (n=34) | Low, n (n=34) | P-value (χ2 test) |
| Age, years | 0.220 | |||
| <55 | 29 | 17 | 12 | |
| ≥55 | 39 | 17 | 22 | |
| Sex | 0.086 | |||
| Male | 52 | 23 | 29 | |
| Female | 16 | 11 | 5 | |
| HBV infection | 0.457 | |||
| Absent | 27 | 15 | 12 | |
| Present | 41 | 19 | 22 | |
| Tumor size, cm | 0.793 | |||
| <5 | 47 | 23 | 24 | |
| ≥5 | 21 | 11 | 10 | |
| TNM stage | 0.013a | |||
| I–II | 42 | 16 | 26 | |
| III–IV | 26 | 18 | 8 | |
| Lymph node metastasis | 0.026a | |||
| Negative | 27 | 9 | 18 | |
| Positive | 41 | 25 | 16 | |
aStatistically significant. High/low by the sample median value of TMCC1-A1 expression level. HBV, hepatitis B virus; TMCC1-AS1, long non-coding RNA transmembrane and coiled-coil domain family 1 antisense RNA 1.